A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy

The application of machine learning (ML) techniques could facilitate the identification of predictive biomarkers of somatostatin analog (SSA) efficacy in patients with neuroendocrine tumors (NETs). We collected data from 74 patients with a pancreatic or gastrointestinal NET who received SSA as first...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diagnostics (Basel)
Autores principales: Hasic Telalovic, Jasminka, Pillozzi, Serena, Fabbri, Rachele, Laffi, Alice, Lavacchi, Daniele, Rossi, Virginia, Dreoni, Lorenzo, Spada, Francesca, Fazio, Nicola, Amedei, Amedeo, Iadanza, Ernesto, Antonuzzo, Lorenzo
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145352/
https://ncbi.nlm.nih.gov/pubmed/33925256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11050804
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares